BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$301.92 USD
+5.10 (1.72%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $302.11 +0.19 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Bio-Rad Laboratories, Inc. [BIO]
Reports for Purchase
Showing records 121 - 140 ( 145 total )
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
We are discontinuing coverage of Bio-Rad Laboratories
Provider: G.RESEARCH, LLC
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Terminating Coverage Due to Analyst Departure.
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
BIO: 2Q:12 Soft Top Line and Inline Bottom Line Excl. One Time Expenses
Provider: COLLIERS SECURITIES
Analyst: HUSAIN J